Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Cian Healthcare Ltd. shows significant potential for growth despite current challenges, particularly in EPS growth, while being overshadowed by peers in profitability and valuation metrics. It presents a unique investment opportunity for those willing to take on higher risk for possible future returns.
Highest revenue growth YoY (18.12%) and strong profitability with high ROE (23.15%) and low debt (0.021).
Strong profitability metrics with high ROE (21.76%) and attractive valuation (PE of 15.50).